ORAMED PHARMACEUTICALS INC
ORMP · NASDAQ
Updated at 2026-10-15 08:39:20
- Today's High
- $4.22
- Today’s Low
- $4.12
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $4.12
- Previous Close
- $4.14
- Volume
- 146.56K
- Market Cap
- $172.21M
- P/E Ratio
- 0.99X
- EPS
- $4.12
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 1185 AVENUE OF THE AMERICAS, NEW YORK, NY, UNITED STATES, 10036
- Country
- US
- Listing Date
- 2002-04-01
- Fiscal Year End
- December
- Shares Outstanding
- 40.93M
- CIK
- 0001176309
- Website
- oramed.com
Oramed Pharmaceuticals Inc. is dedicated to the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for the administration of polypeptides. The company is headquartered in New York, New York.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$2.76M
2026-03-31
$3.65M
2025-12-31
$5.64M
2025-09-30
$2.39M
Net Income
2026-06-30
$78.15M
2026-03-31
$38.31M
2025-12-31
$10M
2025-09-30
$48.39M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.09
2026-03-31
$0.91
2025-12-31
$0.25
2025-09-30
$1.13
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$101.61M
2026-03-31
-$3.62M
2025-12-31
-$5.64M
2025-09-30
$59.48M
Effective Tax Rate
2026-06-30
23.06%
2026-03-31
22.51%
2025-12-31
-2.16%
2025-09-30
18.6%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $2.76M | $3.65M | $5.64M | $2.39M |
| Net Income | $78.15M | $38.31M | $10M | $48.39M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.09 | $0.91 | $0.25 | $1.13 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $101.61M | -$3.62M | -$5.64M | $59.48M |
| Effective Tax Rate | 23.06% | 22.51% | -2.16% | 18.6% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.